NCT06848608 Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in Sarcoidosis
| NCT ID | NCT06848608 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saglik Bilimleri Universitesi |
| Condition | Sarcoidosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2023-11-30 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2023-11-30 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sarcoidosis is a multisystem disease, characterized by the formation of immune granulomas with various clinical symptoms depending on the involved organs, which can involve many organs and systems associated with emotional and physical consequences that affect the quality of life, whose cause is unknown, but usually affects the respiratory system, and occurs mostly in young and middle-aged adults. Lung involvement, seen in 95% of patients, causes limitation of lung capacity and decrease in inspiratory muscle strength, which are important factors that lead to an increase in dyspnea and a decrease in walking distance. In addition to respiratory muscle weakness, skeletal muscle dysfunction is also frequently observed. The most common symptoms in sarcoidosis are dyspnea and fatigue. When the current literature is examined, it can be seen that studies on non-pharmacological treatment methods in Sarcoidosis are quite limited. Although relatively common in Chronic Obstructive Pulmonary Disease (COPD), various studies conducted in patients with Bronchiectasis, Pulmonary Arterial Hypertension and Asthma have shown that yoga results in a decrease in dyspnea and fatigue, and an increase in pulmonary functions and exercise capacity. On the other hand, no study has been found on yogic techniques in Sarcoidosis. Aim of this study is to investigate the effects of yogic techniques and conventional physiotherapy program on pulmonary functions, body oxygen level test (BOLT), exercise capacity (6MWT), anxiety, depression, fatigue, dyspnea perception, sleep quality, and quality of life in sarcoidosis cases at different stages. In these patients known to have multisystem involvement, holistic approaches gain importance due to the nature of the disease.
Eligibility Criteria
Inclusion Criteria: * Being diagnosed with Sarcoidosis by a physician (Stage II-III-IV) * Pulmonary involvement * Having fatigue symptoms (FAS ≥22 points) * No immunosuppressive drug use for the last 1 year * No antidepressant use for the last 6 months Exclusion Criteria: * Presence of cognitive impairment that prevents communication * Anemia * Uveitis * Diabetes * Pregnancy * Major cardiovascular diseases * Fractures * Osteoporosis * Those who have a neurological or orthopedic disease that will affect the treatment * Those who are in the exacerbation period of the disease * Tumor
Contact & Investigator
Zuhal D TAKİNACI, PT, Asst Prof
STUDY CHAIR
University of Health science
Frequently Asked Questions
Who can join the NCT06848608 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Sarcoidosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06848608 currently recruiting?
Yes, NCT06848608 is actively recruiting participants. Contact the research team at yildizseydaa@gmail.com for enrollment information.
Where is the NCT06848608 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06848608 clinical trial?
NCT06848608 is sponsored by Saglik Bilimleri Universitesi. The principal investigator is Zuhal D TAKİNACI, PT, Asst Prof at University of Health science. The trial plans to enroll 32 participants.